Meet Oleg Borisenko at the 2nd Annual Medical Devices Sales and Marketing Conference in Cologne, Germany

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to better understand the potential scope of our support. From the week of 29th of July, we are planning to work on 21 projects. Review the full list of planned activities in this post.

MTRC developed an analytical White Paper with a summary of key market access elements of EU5 countries, including stakeholders, payment mechanisms, innovative payment schemes, funding, and the role of HTA for in-vitro diagnostic tests.

In a new White Paper, MTRC identified evidence requirements for the creation of CCAM codes for diagnostic (non-IVD) procedures performed by physicians based on an analysis of four recent HAS reports with positive and negative recommendations. The analysis was performed in February 2024.

Market access is a rapidly changing field and the landscape varies for different types of medical technologies. To provide an additional, easy-to-access source of high-level information about key themes in the market access landscape and challenges for individual types of medical technologies, MTRC launched a dedicated Knowledge Zone on the website. Currently, the Knowledge Zone includes information about procedure coding, payment mechanisms, policy considerations, HTA, and future challenges for market access for 12 types of medical technologies. In the coming weeks, the Zone will expand 40 key technology groups

In a new White Paper, MTRC identified evidence requirement pitfalls that act as a barrier to listing in the LPPR based on analyzing five recent HAS reports with negative recommendations from different medical disciplines. The analysis was performed in January 2024.